May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Long Term Results Uveal Lymphoid Infiltration Hyperplasia Treated With Radiation
Author Affiliations & Notes
  • L. Harris
    Emory, Atlanta, GA
    Ophthalmology,
  • T.M. Aaberg, Sr.
    Emory, Atlanta, GA
    Ophthalmology,
  • I. Crocker
    Emory, Atlanta, GA
    Radiation Oncology,
  • D.F. Martin
    Emory, Atlanta, GA
    Ophthalmology,
  • Footnotes
    Commercial Relationships  L. Harris, None; T.M. Aaberg, None; I. Crocker, None; D.F. Martin, None.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2824. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Harris, T.M. Aaberg, Sr., I. Crocker, D.F. Martin; Long Term Results Uveal Lymphoid Infiltration Hyperplasia Treated With Radiation . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2824.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To report long term results of seven eyes of six patients with uveal lymphoid infiltration refractory to medical therapy that were treated with radiation at the Emory Eye Center from 1995 to 2005.

Methods: : A retrospective case series of seven eyes of six consecutive patients referred to the Emory Eye Center from 1995 to 2005 with uveal lymphoid infiltration that were treated with radiation after medical therapy failed. Main outcome measures were visual acuity and inactivity of the disease. Inactivity was defined as exudative retinal detachment resolution.

Results: : Seven eyes of six patients were diagnosed with uveal lymphoid infiltration. All patients had diffuse choroidal thickening, exudative retinal detachments and peripapillary nodules evident on ultrasonography. One patient had orbital involvement. All patients failed oral steroid treatment. One patient failed intravenous steroid treatment; two patients failed retroseptal steroid treatment. One patient failed treatment with methotrexate. Subsequently all patients received radiation in divided doses. Five eyes received 20 gray with 2 gray per fraction. Two eyes received 27 gray with 1.8 gray per fraction. Pretreatment visual acuity was HM, HM, NLP (patient with orbital involvement), 20/400, 20/30, 20/40, and 20/400. Posttreatment visual acuity was HM, 20/80, NLP, 20/400, 20/20, 20/30 and 20/20, respectively. The patient with orbital involvement and NLP visual acuity died within one month of radiotherapy secondary to complications of metastatic renal cell carcinoma. The remaining six eyes achieved resolution of exudative detachments. Followup after radiation treatment was 27.6 months (range one month to 101 months).

Conclusions: : Radiation was an effective treatment for uveal lymphoid hyperplasia refractory to medical treatment in this case series. Visual acuities of four eyes improved; visual acuities of two eyes remained unchanged. One patient died of complications of metastatic renal cell carcinoma. Inactivity was achieved in the remaining six eyes. For uveal lymphoid hyperplasia, radiotherapy appears to be effective in long term maintenance of visual acuity and inactivity of disease.

Keywords: oncology • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×